KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $530.0 million.

  • Moderna's Other Non-Current Assets fell 467.63% to $530.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $530.0 million, marking a year-over-year decrease of 467.63%. This contributed to the annual value of $594.0 million for FY2024, which is 2245.43% down from last year.
  • Latest data reveals that Moderna reported Other Non-Current Assets of $530.0 million as of Q3 2025, which was down 467.63% from $546.0 million recorded in Q2 2025.
  • Moderna's 5-year Other Non-Current Assets high stood at $1.3 billion for Q2 2023, and its period low was $11.0 million during Q1 2021.
  • Its 5-year average for Other Non-Current Assets is $485.1 million, with a median of $556.0 million in 2024.
  • As far as peak fluctuations go, Moderna's Other Non-Current Assets soared by 204782.61% in 2022, and later plummeted by 5031.01% in 2024.
  • Moderna's Other Non-Current Assets (Quarter) stood at $46.0 million in 2021, then surged by 2047.83% to $988.0 million in 2022, then fell by 22.47% to $766.0 million in 2023, then fell by 22.45% to $594.0 million in 2024, then dropped by 10.77% to $530.0 million in 2025.
  • Its Other Non-Current Assets stands at $530.0 million for Q3 2025, versus $546.0 million for Q2 2025 and $556.0 million for Q1 2025.